141 related articles for article (PubMed ID: 15912720)
1. Coerced treatment for methamphetamine abuse: differential patient characteristics and outcomes.
Brecht ML; Anglin MD; Dylan M
Am J Drug Alcohol Abuse; 2005; 31(2):337-56. PubMed ID: 15912720
[TBL] [Abstract][Full Text] [Related]
2. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
Grella CE; Hser YI; Huang YC
Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
[TBL] [Abstract][Full Text] [Related]
3. Social pressure, coercion, and client engagement at treatment entry: a self-determination theory perspective.
Wild TC; Cunningham JA; Ryan RM
Addict Behav; 2006 Oct; 31(10):1858-72. PubMed ID: 16480834
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002).
Brecht ML; Greenwell L; Anglin MD
J Subst Abuse Treat; 2005 Dec; 29(4):295-306. PubMed ID: 16311182
[TBL] [Abstract][Full Text] [Related]
5. Treatment response by primary drug of abuse: does methamphetamine make a difference?
Luchansky B; Krupski A; Stark K
J Subst Abuse Treat; 2007 Jan; 32(1):89-96. PubMed ID: 17175402
[TBL] [Abstract][Full Text] [Related]
6. Client retention in residential drug treatment for Latinos.
Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
[TBL] [Abstract][Full Text] [Related]
7. Profiles of club drug users in treatment.
Maxwell JC; Spence RT
Subst Use Misuse; 2005; 40(9-10):1409-26. PubMed ID: 16048825
[TBL] [Abstract][Full Text] [Related]
8. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
[TBL] [Abstract][Full Text] [Related]
9. Trends in drop out, drug free discharge and rates of re-presentation: a retrospective cohort study of drug treatment clients in the North West of England.
Beynon CM; Bellis MA; McVeigh J
BMC Public Health; 2006 Aug; 6():205. PubMed ID: 16904004
[TBL] [Abstract][Full Text] [Related]
10. A comparison of adolescent methamphetamine and other substance users in Hawai'i.
Kim RJ; Jackson DS
Hawaii Med J; 2008 Nov; 67(11):294-300, 302. PubMed ID: 19226910
[TBL] [Abstract][Full Text] [Related]
11. The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
Elkashef A; Rawson RA; Smith E; Pearce V; Flammino F; Campbell J; Donovick R; Gorodetzky C; Haning W; Mawhinney J; McCann M; Weis D; Williams L; Ling W; Vocci F
Addiction; 2007 Apr; 102 Suppl 1():107-13. PubMed ID: 17493059
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
[TBL] [Abstract][Full Text] [Related]
13. Cannabis treatment outcomes among legally coerced and non-coerced adults.
Copeland J; Maxwell JC
BMC Public Health; 2007 Jun; 7():111. PubMed ID: 17567917
[TBL] [Abstract][Full Text] [Related]
14. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005.
Callaghan RC; Brands B; Taylor L; Lentz T
J Adolesc Health; 2007 Mar; 40(3):286-9. PubMed ID: 17321434
[TBL] [Abstract][Full Text] [Related]
15. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
[TBL] [Abstract][Full Text] [Related]
17. Integrating research and practice in the CSAT Methamphetamine Treatment Project.
Hamilton Brown A
J Subst Abuse Treat; 2004 Mar; 26(2):103-8. PubMed ID: 15050087
[TBL] [Abstract][Full Text] [Related]
18. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
19. Predicting in-treatment performance and post-treatment outcomes in methamphetamine users.
Hillhouse MP; Marinelli-Casey P; Gonzales R; Ang A; Rawson RA;
Addiction; 2007 Apr; 102 Suppl 1():84-95. PubMed ID: 17493057
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
Yeom HS; Shepard DS
J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
